Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MRVI

Maravai LifeSciences (MRVI)

Maravai LifeSciences Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRVI
DateTimeSourceHeadlineSymbolCompany
13/05/202422:00Business WireTriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation CenterNASDAQ:MRVIMaravai LifeSciences Holdings Inc
10/05/202406:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
10/05/202406:05GlobeNewswire Inc.Maravai LifeSciences Announces May and June 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/05/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/05/202406:05GlobeNewswire Inc.Maravai LifeSciences Reports First Quarter 2024 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
01/05/202406:49Business WireTriLink BioTechnologies® et Lonza signent un contrat de licence et d'approvisionnement non exclusif pour la technologie de capsulage d'ARNm CleanCap®NASDAQ:MRVIMaravai LifeSciences Holdings Inc
01/05/202406:49Business WireTriLink BioTechnologies® und Lonza schließen nicht-exklusiven Lizenz- und Liefervertrag für CleanCap® mRNA Capping Technologie abNASDAQ:MRVIMaravai LifeSciences Holdings Inc
30/04/202421:31Business WireTriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping TechnologyNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/04/202405:12Business WireTriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développementNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/04/202405:09Business WireTriLink BioTechnologies® kündigt neue Anlage in San Diego zur mRNA-Produktion von Arzneimittelwirkstoffen in der Spätphase anNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/04/202421:36Business WireTriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionNASDAQ:MRVIMaravai LifeSciences Holdings Inc
11/04/202406:05GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
13/03/202407:15GlobeNewswire Inc.Maravai LifeSciences Announces March 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
01/03/202409:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
23/02/202408:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
23/02/202408:05GlobeNewswire Inc.Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
22/02/202400:00Business WireTriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and CanadaNASDAQ:MRVIMaravai LifeSciences Holdings Inc
21/02/202410:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
14/02/202400:30GlobeNewswire Inc.Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in BiomanufacturingNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/02/202408:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
30/01/202400:00GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/01/202410:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/01/202410:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/01/202410:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/01/202410:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
19/01/202410:15Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
17/11/202309:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
10/11/202300:15GlobeNewswire Inc.Maravai LifeSciences Announces November 2023 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/11/202309:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
08/11/202308:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:MRVI